Blog

  1. Want to succeed in the Western Blot antibody market?

    Our latest data report focuses on how your company can succeed in the Western Blot antibody market. This builds on our recent blogs which explored techniques for success in IHC and Flow Cytometry, and outlines what suppliers need to offer in order to increase their market share. To produce the data in this report, our […]

  2. Room for growth at Abcam?

      As we approach the announcement of Abcam’s end of year results in September, our latest data report looks at how the company has done historically, how it is currently performing, and what the future might hold. Abcam, a Cambridge, UK based company operating on a global scale, has seen steady growth over the last […]

  3. Support the movement – antibody validation

    As a regular to the CiteAb blog you’ll be well aware of our mission to improve antibody validation, sharing resources with you regularly. Today we want to flag that in addition to the 2nd International Antibody Validation Event that we’re helping with on 15 & 16 September here in Bath, UK, there is a second […]

  4. Win tickets to AbVal16!

    Here at CiteAb we have two tickets for the 2nd International Antibody Validation Event up for grabs – read on to find out how you can get them. The 2nd Antibody Validation Event promises to be an unique meeting, bringing together scientists from academia, the pharmaceutical / biotech sector and antibody suppliers in order to […]

  5. So you want to succeed in the flow cytometry antibody market?

    In our latest targeted data report we’re outlining the key players in the flow cytometry antibody market, highlighting those companies that are doing particularly well and also those that could grow in this field. As with all CiteAb data, the numbers behind this report are the result of the analysis of hundreds of thousands of […]

Search our blog